NNovo Nordisk Read More Here’s Why Agios Pharmaceuticals Crashed 23% Today2026-04-21 Key Points Agios Pharmaceuticals shares dropped 23% following Novo Nordisk’s trial results. Novo’s etavopivat outperformed Agios’ mitapavit in…